Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AG Monoclonal antibodies
L04AG13 Teprotumumab
D09680 Teprotumumab (USAN/INN) <US>
USP drug classification [BR:br08302]
Ophthalmic Agents
Ophthalmic Agents, Other
Teprotumumab
D09680 Teprotumumab (USAN/INN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
INSR family
IGF1R (CD221)
D09680 Teprotumumab (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09680
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09680